Biobanking is essential to support HPV -associated basic and clinical research. A recent survey of key opinion leaders confirmed this as a top 10 priority for HPV based research and development. Some of the key considerations for biobanking are: to ensure samples are stored and disseminated with due process of governance; ensuring samples are of the nature and quality to support contemporary, priority research; and sustainability models.
|Publication status||Published - Dec 2018|
|Event||EUROGIN 2018 - From control to elimination of HPV induced cancers - Lisbon, Portugal|
Duration: 2 Dec 2018 → 5 Dec 2018
|Conference||EUROGIN 2018 - From control to elimination of HPV induced cancers|
|Abbreviated title||Eurogin 2018|
|Period||2/12/18 → 5/12/18|